An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Clinical Excellence (NICE); 2012 Sep. (NICE Clinical Guidelines, No. 151.)
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Bladder Cancer: Diagnosis and Management.
London: National Institute for Health and Care Excellence (NICE); 2015 Feb. (NICE Guideline, No. 2.)
Pancreatic cancer in adults: diagnosis and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Feb. (NICE Guideline, No. 85.)
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Addendum to Haematological Cancers: improving outcomes (update).
London: National Institute for Health and Care Excellence (NICE); 2016 May.
Non-Hodgkin's Lymphoma: Diagnosis and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision.
Geneva: World Health Organization; 2010.
Guidelines for the Management of α-Thalassaemia [Internet].
Amid A, Lal A, Coates TD, et al., editors.
Nicosia (Cyprus): Thalassaemia International Federation; 2023.
Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision.
Emergency and acute medical care in over 16s: service delivery and organisation.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 94.)
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd edition.
Geneva: World Health Organization; 2016.
Guidelines for the treatment of human African trypanosomiasis [Internet].
Geneva: World Health Organization; 2024 Jun.
Substance Abuse Treatment for Persons With HIV/AIDS [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2000. (Treatment Improvement Protocol (TIP) Series, No. 37.)
Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto): CADTH Reimbursement Review: Therapeutic area: Metastatic castration-resistant prostate cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.
Guidelines for the Clinical Management of Thalassaemia [Internet]. 2nd Revised edition.
Cappellini MD, Cohen A, Eleftheriou A, et al.
Nicosia (CY): Thalassaemia International Federation; 2008.
Manual on Paediatric HIV Care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children.
Geneva: World Health Organization; 2011.
Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach [Internet].
Geneva: World Health Organization; 2021 Jul.
Early and locally advanced breast cancer: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2024 Jan 16. (NICE Guideline, No. 101.)
Sacituzumab Govitecan (Trodelvy): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+, or IHC 2+/ISH–) breast cancer who have received endocrine-based therapy and at least 2 additional systemic therapies in the metastatic setting [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on